BIOM-13. DNA METHYLATION MARKS GLUCOCORTICOID PATHWAY RESPONSE IN DEXAMETHASONE-TREATED BRAIN TUMOR PATIENTS

Dexamethasone (DEX) is routinely prescribed in brain tumor patients to limit vasogenic edema but may also exacerbate immunosuppression and adversely affect survival. The wide spectrum of dosing and individual variation in glucocorticoid (GC) response makes it difficult to assess the impact of DEX ex...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Wiencke, John, Molinaro, Annette, Warrier, Gayathri, Rice, Terri, Clarke, Jennifer, Taylor, Jennie, Wrensch, Margaret, Tamaki, Stanley, Lee, JiYoon, Hansen, Helen, McCoy, Lucie, Bracci, Paige, Salas, Lucas, Koestler, Devin, Christensen, Brock, Kelsey, Karl
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2020
Soggetti:
Biomarkers
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650309/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.013
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi